Peer-reviewed preclinical melanoma research finds Provectus’s synthetic small molecule can both stimulate anti-tumor immunity and suppress peripheral immune cells at the same dose.

UCSF researchers are using tiny "mini-organs" to model disease, personalize treatment, and understand human development. They ...

Ms. Washburn has over 20 years of experience in leadership roles in the pharmaceutical and biotech sectors; Corporate focus on delivering top-line results from the Phase 2b clinic ...

When injected into mice with retinal disease, the special retinal blood cells integrated into the damaged tissue to ...

True anti-aging mastery is shifting its focus away from freezing facial expressions and toward optimizing the natural, ...

Explore how space oncology could transform cancer treatment through microgravity research and innovative drug development ...

Getting it over the finish line was a labor of love—and now, more than five years after her death, the lab of former Sloan ...

Northwestern Medicine scientists have discovered that one of the body's most fundamental biological processes—how red blood ...

In mice, scientists have now nudged that same emergency repair program onto a different path. By applying two growth signals ...

Summary: Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized the treatment of liquid blood cancers by engineering a patient’s own immune cells to destroy malignant targets, replicating ...

Engineered tissue grafts could help perform key liver functions and benefit thousands of people living with liver failure.

Blind people have been offered fresh hope of seeing again after lab-grown cells restored retinal function in mice. The ...